DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Racivir
Racivir
Nnrtis – MK1439 New Classes • Maturation Inhibitors, LEDGINS, Etc
HIV/AIDS Technologies: a Review of Progress to Date and Current Prospects
Multi-Class Immune-Based Therap I Es Co Combination Drugs AZ T
AVCC Figure Template
This Project Has Been Supported with Unrestriced Grants from Abbvie Gilead Sciences HEXAL Janssen-Cilag MSD Viiv Healthcare By
Wo 2009/148600 A2
What's in the Pipeline: New HIV Drugs, Vaccines, Microbicides, HCV And
Background Paper 6.7 Human Immunodeficiency Virus (HIV)/ Acquired Immune Deficiency Syndromes (AIDS)
Dedication to Kyoichi A. Watanabe
1 Outlook of the Antiviral Drug Era, Now More Than 50 Years After Description of the First Antiviral Drug Erik De Clercq
The Impact of Modern Antiretroviral Therapy on Lipid Metabolism of HIV-1 Infected Patients
Frequência De Factores De Risco Cardiovascular E Doença Cardíaca
2013 Prioritisation Report Priority Antiretrovirals for the Medicines
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
Hoffmann Rockstroh |
WO 2017/048727 Al 23 March 2017 (23.03.2017) P O P C T
Advances in Antiretroviral Therapy Volume 11 Issue 3 May/June 2003
CDR Clinical Review Report for Biktarvy
Top View
WO 2014/184553 Al 20 November 2014 (20.11.2014) P O P C T
Avexa's Partnering Problems Could Be Contagious in HIV Space
WO 2013/167743 Al 14 November 2013 (14.11.2013) P O P C T
TABLE 2. HIV Treatment Pipeline 2003–2012 Class Drug Name Generic Name Brand Name Sponsor 2003 2004 2005 2006 2007 2008 2009 2
Entry Inhibitors
Antiviral Drugs
Cdr Clinical Review Report for Truvada
WO 2013/116720 Al 8 August 2013 (08.08.2013) P O P C T
WHO Treatment 2 0 by C. Mcclure, Department of HIV and AIDS
An Overview on Hiv-1 Reverse Transcriptase Inhibitors
PMT HIV Article August 2005
New Concepts in Anti-Hiv Therapies
Review Novel Compounds for the Treatment of HIV Type-1 Infection
Nucleoside Analog Reverse Transcriptase Inhibitors In
TLALELETSO New Antiretrovirals
(12) United States Patent (10) Patent No.: US 8,703,801 B2 Nair Et Al
COVID User's Guide (Updated: 14/12/2020)
WO 2012/151165 Al 8 November 2012 (08.11.2012) P O P C T
Antibiotic Pipeline Surveillance – 2010 to Mid 2011 Cardinal Health Clinical Affairs (Phase I and Some Early Phase II Not Included)
March Hiv Issue 1-16
2013 Pipeline Report
Recent Developments in HIV Treatment and Their Dissemination in Poor
Cdr Clinical Review Report for Genvoya
HIV/AIDS in Practice an Expert Commentary with Joseph J. Eron
HIV, HCV, TB: 2012 Pipeline Report, TAG and I-Base
(12) Patent Application Publication (10) Pub. No.: US 2008/0241289 A1 Gant Et Al
Antiviral Efficacy of Nine Nucleoside Reverse Transcriptase Inhibitors Against Feline Immunodeficiency Virus in Feline Peripheral Blood Mononuclear Cells
2011 Pipeline Report Second Edition
World Journal of Virology
(12) Patent Application Publication (10) Pub. No.: US 2005/0209196A1 Chu Et Al
120 Region of HIV-1 Env, Especially in the V2 and V3 Regions – Switching Co-Receptor Usage • CCR5 CXCR4